NALDINI, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 19.984
EU - Europa 15.180
AS - Asia 8.596
SA - Sud America 1.303
AF - Africa 363
Continente sconosciuto - Info sul continente non disponibili 174
OC - Oceania 36
Totale 45.636
Nazione #
US - Stati Uniti d'America 19.697
CN - Cina 3.264
GB - Regno Unito 3.183
SG - Singapore 2.778
RU - Federazione Russa 2.720
IT - Italia 2.059
IE - Irlanda 1.932
UA - Ucraina 1.269
SE - Svezia 1.131
BR - Brasile 1.042
DE - Germania 1.001
FR - Francia 976
VN - Vietnam 659
HK - Hong Kong 611
FI - Finlandia 511
KR - Corea 449
IN - India 212
ZA - Sudafrica 191
CA - Canada 129
BD - Bangladesh 121
MX - Messico 86
AR - Argentina 80
TR - Turchia 79
ES - Italia 71
JP - Giappone 70
IQ - Iraq 55
NL - Olanda 53
EC - Ecuador 52
PL - Polonia 51
PK - Pakistan 46
CO - Colombia 44
CZ - Repubblica Ceca 37
AU - Australia 33
VE - Venezuela 33
ID - Indonesia 32
MA - Marocco 30
NG - Nigeria 30
BE - Belgio 28
AT - Austria 27
UZ - Uzbekistan 24
CL - Cile 22
KE - Kenya 22
MY - Malesia 22
AE - Emirati Arabi Uniti 21
CI - Costa d'Avorio 21
PH - Filippine 21
SA - Arabia Saudita 18
EG - Egitto 16
RO - Romania 16
LT - Lituania 15
TN - Tunisia 15
DK - Danimarca 14
ET - Etiopia 14
JM - Giamaica 14
DZ - Algeria 12
JO - Giordania 12
KZ - Kazakistan 12
AZ - Azerbaigian 11
HU - Ungheria 11
NP - Nepal 11
BO - Bolivia 10
CH - Svizzera 10
PY - Paraguay 10
DO - Repubblica Dominicana 8
EU - Europa 8
CR - Costa Rica 7
HN - Honduras 7
TH - Thailandia 7
TT - Trinidad e Tobago 7
AL - Albania 6
EE - Estonia 6
GR - Grecia 6
IL - Israele 6
IR - Iran 6
PT - Portogallo 6
QA - Qatar 6
BG - Bulgaria 5
GT - Guatemala 5
KG - Kirghizistan 5
LB - Libano 5
LV - Lettonia 5
NI - Nicaragua 5
NO - Norvegia 5
SY - Repubblica araba siriana 5
BB - Barbados 4
BY - Bielorussia 4
LU - Lussemburgo 4
PA - Panama 4
PE - Perù 4
PR - Porto Rico 4
TW - Taiwan 4
UY - Uruguay 4
AM - Armenia 3
CG - Congo 3
KW - Kuwait 3
MD - Moldavia 3
MN - Mongolia 3
OM - Oman 3
RS - Serbia 3
SV - El Salvador 3
Totale 45.428
Città #
Southend 2.847
Menlo Park 2.481
Dallas 2.184
Dublin 1.924
Singapore 1.542
Ashburn 1.206
Chandler 1.184
Fairfield 1.083
Jacksonville 1.041
San Jose 962
Santa Clara 877
Beijing 814
Moscow 718
Milan 648
Hong Kong 589
Wilmington 541
Hefei 526
Woodbridge 510
Ann Arbor 500
Council Bluffs 451
Seoul 447
Houston 410
Cambridge 406
Seattle 405
Nanjing 355
Princeton 339
Siena 314
The Dalles 289
Los Angeles 247
Helsinki 234
Rome 212
Ho Chi Minh City 211
New York 201
Lauterbourg 190
Boardman 183
Johannesburg 163
Munich 153
Hanoi 146
Buffalo 123
Nanchang 115
Orem 97
San Mateo 97
São Paulo 89
San Diego 86
Shanghai 85
Shenyang 80
Dearborn 71
Figino 68
London 65
Tianjin 64
Frankfurt am Main 59
Kunming 58
Columbus 57
Chennai 56
Chicago 56
Tokyo 53
Changsha 52
Hebei 52
Turku 52
Florence 51
Brooklyn 50
Bengaluru 49
Redondo Beach 49
Jiaxing 47
Phoenix 46
Fremont 45
Düsseldorf 44
Redwood City 44
Manchester 42
Turin 42
Dong Ket 41
Atlanta 39
San Francisco 39
Warsaw 39
Da Nang 38
Montreal 36
Málaga 36
Norwalk 36
Jinan 34
Toronto 33
Amsterdam 32
Washington 32
Izmir 31
Rio de Janeiro 31
Zhengzhou 31
Guangzhou 30
Venezia 29
Abuja 28
Hangzhou 28
Ningbo 27
Brussels 26
Prato 26
Belo Horizonte 25
Dhaka 25
Haiphong 25
Stockholm 25
Olomouc 24
Philadelphia 24
Boston 23
Tashkent 23
Totale 30.493
Nome #
2-Hydroxypropyl-β-cyclodextrin strongly improves water solubility and anti-proliferative activity of pyrazolo[3,4-d]pyrimidines Src-Abl dual inhibitors 416
Different adaptive responses to hypoxia in normal and multiple myeloma endothelial cells 382
3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitors 378
The Shc protein RAI promotes an adaptive cell survival program in hypoxic neuroblastoma cells 341
Novel acylguanidine derivatives targeting smoothened induce antiproliferative and pro-apoptotic effects in chronic myeloid leukemia cells 330
Adaptative cellular responses to hypoxia: role of HIF-1 dependent genes in endothelial cell autophagy and survival 320
N-[2-Methyl-5-(triazol-1-yl)phenyl]pyrimidin-2-amine as a scaffold for the synthesis of inhibitors of Bcr-Abl 315
Administration of interferons and interleukin 2 via the lymphatic route 313
Design, synthesis, biological activity and ADME properties of pyrazolo[3,4-d]pyrimidines active in hypoxic human leukemia cells: a lead optimization study 307
Analysis of protease-activated receptor-1 and -2 in human scar formation 306
Short-term hypoxia enhances the migratory capability of dendritic cell through HIF-1α and PI3K/Akt pathway 305
The adaptor protein p66Shc is a positive regulator in the angiogenic response induced by hypoxic T cells 296
Concentrazioni plasmatiche e tissutali di interferone in pazienti sottoposti a resezione chirurgica per cancro polmonare 296
Different Expression of Hypoxic and Angiogenic Factors in Human Endometriotic Lesions 294
A Ribonuclease Protection Assay-Based Approach for Analysis of Angiogenic Gene Expression in Archival Tissues 289
Cell growth inhibition by interferon in hypoxia 286
The Shc protein Rai enhances T-cell survival under hypoxia 284
Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor-C expression in head and neck squamous cell carcinoma 277
Identification of thrombin-like activity in ovarian cancer associated ascites and modulation of multiple cytokine networks 275
Administration of the interferons via the lymphatic route 275
Early response to bleomycin is characterized by different cytokine and cytokine receptor profiles in lungs 273
Downregulation of hypoxia-related responses by novel antitumor histone deacetylase inhibitors in MDAMB231 breast cancer cells 273
Thrombin regulates the expression of pro-angiogenic cytokines via proteolytic activation of protease-activated receptor-1 271
Neuroglobin in Breast Cancer Cells: Effect of Hypoxia and Oxidative Stress on Protein Level, Localization, and Anti-Apoptotic Function 270
Fisiologia Renale in Fisiologia Medica di Ganong 13 edizione italiana 270
Hydroxylase Inhibition Selectively Induces Cell Death in Monocytes 269
L'ipossia induce l'espressione del recettore attivato da proteasi-1(PAR-1) nelle cellule MDA-MB-231 mediante l'accumulo del fattore indotto dall'ipossia-1alfa 265
Effects of astrocytoma cells conditioned medium on differentiated neuroblastoma cells subjected to hypoxia and reperfusion 265
Thrombin-mediated IL-10 up-regulation involves protease-activated receptor (PAR)-1 expression in human mononuclear leukocytes 262
The adaptor protein p66shc is a positive regulator in the angiogenic response induced by hypoxic T cells 262
Alanine kinetics in humans during low-intensity exercise 260
Carbonic anhydrase XII expression is linked to suppression of Sonic hedgehog ligand expression in triple negative breast cancer cells 259
Pyrazolo[3,4-d]pyrimidines as potent antiproliferative and proapoptotic agents toward A431 and 8701-BC cells in culture via inhibition of c-Src phosphorylation 255
Hypoxia and immune surveillance: role of the adaptor protein p66ShcA in negative regulation of T-cell activation and survival ' 255
Inhibition of smoothened in breast cancer cells reduces CAXII expression and cell migration 255
Hypoxia Shapes Autophagy in LPS-Activated Dendritic Cells 255
Bulk preparation of hepatic binding protein 254
Colorectal administration of human interferon -alpha 253
Hypoxia affects dendritic cell survival: Role of the hypoxia-inducible factor-1α and lipopolysaccharide 252
Dendritic cell-derived VEGF-A plays a role in inflammatory angiogenesis of human secondary lymphoid organs and is driven by the coordinated activation of multiple transcription factors 248
Protease-activated receptor-1 (PAR-1) promotes the motility of human melanomas and is associated to their metastatic phenotype 248
Role of inflammatory mediators in angiogenesis 241
Interleukin 10 production in patients undergoing cardiopulmonary bypass: evidence of inhibition of th-1-type responses 241
New pyrazolo[3,4-d]pyrimidines endowed with A431 antiproliferative activity and inhibitory properties of Src phosphorylation 241
Cutting edge: IL-1beta mediates the proangiogenic activity of osteopontin-activated human monocytes 239
In vitro cytokine production and T-cell proliferation in patients undergoing cardiopulmonary by-pass 238
Thrombin enhancement of interleukin-1 expression in mononuclear cells: involvement of proteinase-activated receptor-1 238
Hypoxia induces the expression and release of interleukin 1 receptor antagonist in mitogen-activated mononuclear cells 236
Inhibition of melanoma cell migration and invasion targeting the hypoxic tumor associated caxii 235
Analysis of HIF-1 alpha and HIF-2 alpha in dendritic cells stimulated under hypoxic conditions 234
Pyrazolo[3,4-d]pyrimidines Endowed with Antiproliferative Activity on Ductal Infiltrating Carcinoma Cells 234
Distribution of human recombinant interferon-alpha 2 in rat plasma, liver, and experimental liver metastases 232
Pro·angiogenic signaling in neuroblastoma: interplay between HIF-1a and Shc C adaptor protein 230
GM-CSF inhibits c-Kit and SCF expression by bone marrow-derived dendritic cells 229
Apoliprotein E-mediated ferroptosis controls cellular proliferation in chronic lymphocytic leukemia 228
Different expression of cytokines and receptors in bleomycin-sensitive and resistant mice 227
Regulation of angiogenesis by Th1- and Th2-type cytokines 227
‘HIF-1 dependent adaptative responses to hypoxia: pro-survival and pro-apoptotic signaling pathways 226
Thrombin inhibits IFN-gamma production in human peripheral blood mononuclear cells by promoting a Th2 profile 225
HIF-1 upregulation by IL-1 contributes to the migratory potential of breast cancer cells 225
Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma 224
Plasma kinetics, distribution and fate of tumor necrosis factor 223
The possible role of T cells and neutrophils in the regulation of tumour angiogenesis 223
Plasma levels of immunosuppressive mediators during cardiopulmonary bypass 223
Identification of a functional role for the protease-activated receptor-1 in hypoxic breast cancer cells 221
Interferon (IFN) levels in human pulmonary tumors 219
Inhibition of interleukin-12 expression by alpha-thrombin in human peripheral blood mononuclear cells: a potential mechanism for modulating Th1/Th2 responses 217
The effects of autologous platelet gel on inflammatory cytokine response in human peripheral blood mononuclear cells 217
Protease-activated receptor 1-selective antagonist SCH79797 inhibits cell proliferation and induces apoptosis by a protease-activated receptor 1-independent mechanism 216
Alpha-thrombin reverses differentiation-related changes in expression of P21CIP1/WAF1 in interferon-gamma differentiated monocytic cells 216
Hypoxia induces the expression of protease-activated receptor (PAR)-1 through the hypoxic inducible factor (HIF)-1alpha in breast cancer cells 215
CA-IX-Expressing Small Extracellular Vesicles (sEVs) Are Released by Melanoma Cells under Hypoxia and in the Blood of Advanced Melanoma Patients 213
Human alpha-Thrombin Stimulates Proliferation of Interferon-gamma Differentiated, Growth-Arrested, U937 Cells, Overcoming Differentiation-Related Changes in Expression of p21CIP1/WAF1 and Cyclin D1 213
Human colorectal cancer: upregulation of the adaptor protein Rai in TILs leads to cell dysfunction by sustaining GSK-3 activation and PD-1 expression 212
Thrombin enhances T cell proliferative responses and cytokine production 211
Interleukin-1β Affects MDAMB231 Breast Cancer Cell Migration under Hypoxia: Role of HIF-1αand NFκB Transcription Factors 211
Targeting hypoxia signaling pathways in angiogenesis 210
Hypoxia affects cytokine production and proliferative responses by human peripheral mononuclear cells 210
Pharmacokinetics of human lymphoblastoid interferon in rabbits 209
Structure-Based Optimization of Pyrazolo[3,4-d]pyrimidines as Abl Inhibitors and Antiproliferative Agents toward Human Leukemia Cell Lines. 208
Hypoxia triggers autophagy in human monocyte-derived dendritic cells 207
Hypoxia modulates cyclin and cytokine expression and inhibits peripheral mononuclear cell proliferation 207
Role of p52RAI Shc protein in the adaptive response to hypoxia in T cells 206
SQSTM1/p62 inhibition impairs pro-survival signaling in hypoxic human dendritic cells 205
Studies for the evaluation of oxygenation and ozonation of blood during extracorporeal circulation 204
The thrombin peptide, TP508, enhances cytokine release and activates signaling events 204
Role of the hypoxic microenvironment in the antitumor activity of tyrosine kinase inhibitors 204
Hypoxia induces autophagy in human monocyte-derived dendritic cells: involvement of Class III PI3K/VPS34 203
Angiogenesis in tissue hypoxia 203
Hypoxia induces the expression of protease-activated receptor (PAR)-1 through the hypoxic inducible factor (HIF)-1α in MDA-MB-231 breast cancer cells 203
Human alpha-thrombin as a growth factor: enhancement of T lymphocyte proliferative responses 203
Heparin coating of extracorporeal circuits inhibits cytokine release from mononuclear cells during cardiac operations 202
Hypoxia induces coordinated adaptive responses in SK-N-MC neuronal cells towards a pro-angiogenic and migratory phenotype 201
Hypoxia influences the cellular cross-talk of human dermal fibroblasts. A proteomic approach 200
p66Shc is involved in promoting HIF-1alpha accumulation and cell death in hypoxic T cells 200
Cytokine expression in bleomycin-sensitive and resistant mice 200
Thrombin modulation of natural killer activity in human peripheral lymphocytes 198
Interferon levels in human pulmonary tumors are lower than plasma levels 198
Role of the Hypoxia-Inducible Factor-1alpha and Akt on hypoxia-induced migratory program in dendritic cells 198
Plasma kinetic and catabolic sites of recombinant human tumor necrosis 198
Totale 24.540
Categoria #
all - tutte 135.241
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 135.241


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.966 0 0 138 263 112 35 105 188 117 232 189 587
2022/20234.268 264 265 652 625 450 851 62 332 475 69 145 78
2023/20242.817 115 71 236 127 111 762 1.004 102 14 49 30 196
2024/20255.722 134 336 539 272 777 256 130 335 448 202 608 1.685
2025/202614.065 1.062 2.000 1.723 1.413 2.672 469 1.462 430 628 784 242 1.180
2026/20271.937 610 445 882 0 0 0 0 0 0 0 0 0
Totale 45.636